Should antifibrinolytics be given in all patients with trauma?

Current Opinion in Anaesthesiology

Volumn 25, Issue 3, 2012, Pages 385-388

  Levi, Marcel ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

antifibrinolytics; hemorrhage; prohemostatic drugs; tranexamic acid; trauma

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; LYSINE DERIVATIVE; TRANEXAMIC ACID;

BLEEDING; BRAIN HEMORRHAGE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FIBRINOLYSIS; HUMAN; INJURY; MORTALITY; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT;

ANTIFIBRINOLYTIC AGENTS; CLINICAL TRIALS AS TOPIC; EMERGENCY MEDICAL SERVICES; HEMORRHAGE; HUMANS; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84861101002     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283532b29     Document Type: Review

References (22)

1. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-2311. Review on efficacy and safety of prohemostatic interventions in various clinical settings.
2. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998;186:528-533.
3. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008;64:1211-1217. Interesting article on new pathophysiological insights into the role of coagulation in traumatic bleeding.
4. Levi M. Critical bleeding in surgery: conventional therapy and new prospects. Minerva Anestesiol 2004;70:267-271.
5. Levi M, Vink R, de Jonge E. Prevention and treatment of bleeding by prohemostatic treatment strategies. Wien Med Wochenschr 2003;153:421-425.
6. Levi M, Eerenberg E, Kamphuisen PW. Periprocedural reversal and bridging of anticoagulant treatment. Neth J Med 2011;69:268-273.
7. Levi MM, Eerenberg E, Lowenberg E, Kamphuisen PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med 2010;68:68-76.
8. Lowenberg EC, Meijers JC, Levi M. Platelet-vessel wall interaction in health and disease. Neth J Med 2010;68:242-251.
9. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376:23-32. Very important large multinational randomized controlled trial on efficacy and safety of tranexamic acid in trauma patients demonstrating reduction in mortality.
10. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339:245-253.
11. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-1947.
12. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011: CD001886.
13. Fergusson DA, Hebert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-2331.
14. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096-1101. Important substudy showing time window in which tranexamic acid is effective in trauma patients.
15. Effect of tranexamic acid in traumatic brain injury. a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ 2011;343:d3795.
16. Curry N, Hopewell S, Doree C, et al. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care 2011;15:R92. Overview article meta-analysing all studies on prohemostatic treatment in bleeding trauma patients.
17. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8-15.
18. Guerriero C, Cairns J, Perel P, et al. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011;6:e18987.
19. Sydenham E. Thousands of lives could be saved using tranexamic acid for patients with bleeding trauma. Inj Prev 2011;17:211. Article extrapolating the benefit of universal use of tranexamic acid in trauma patients.
20. Cap AP, Baer DG, Orman JA, et al. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma 2011;71:S9-S14.
21. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010;363:1791-1800.
22. Ubbink DT, Vermeulen H, Knops AM, et al. Implementation of evidencebased practice: outside the box, throughout the hospital. Neth J Med 2011;69:87-94.